Type |
Details |
Score |
Publication |
First Author: |
Bairoch A |
Year: |
1999 |
Journal: |
Database Release |
Title: |
SWISS-PROT Annotated protein sequence database |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2005 |
|
Title: |
Obtaining and Loading Genome Assembly Coordinates from Ensembl Annotations |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics |
Year: |
2010 |
Journal: |
Database Release |
Title: |
Protein Ontology Association Load. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2005 |
|
Title: |
Obtaining and loading genome assembly coordinates from NCBI annotations |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2009 |
Journal: |
Database Download |
Title: |
Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome 430 2.0 Array Platform |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Pitman JL |
Year: |
2011 |
Journal: |
J Lipid Res |
Title: |
Reduced cholesterol and triglycerides in mice with a mutation in Mia2, a liver protein that localizes to ER exit sites. |
Volume: |
52 |
Issue: |
10 |
Pages: |
1775-86 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Otoraplin, also known as MIAL (MIA-like), is specifically expressed in the cochlea and the vestibule of the inner ear and may contribute to inner ear dysfunction in humans []. It is a member of the MIA family. MIA (melanoma inhibitory activity) family members include MIA, MIAL, MIA2, and MIA3 (also called TANGO). MIA was found to be strongly expressed and secreted by malignant melanomas. It contains a domain that adopts a Src Homology 3 (SH3) domain-like fold; however, it contains an additional antiparallel beta sheet and two disulfide bonds compared to classical SH3 domains. Unlike classical SH3 domains, MIA does not bind proline-rich ligands [, ]. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
Otoraplin, also known as MIAL (MIA-like), is specifically expressed in the cochlea and the vestibule of the inner ear and may contribute to inner ear dysfunction in humans []. It is a member of the MIA family. MIA (melanoma inhibitory activity) family members include MIA, MIAL, MIA2, and MIA3 (also called TANGO). MIA was found to be strongly expressed and secreted by malignant melanomas. It contains a domain that adopts a Src Homology 3 (SH3) domain-like fold; however, it contains an additional antiparallel beta sheet and two disulfide bonds compared to classical SH3 domains. Unlike classical SH3 domains, MIA does not bind proline-rich ligands [, ]. |
|
•
•
•
•
•
|
Publication |
First Author: |
Rendtorff ND |
Year: |
2001 |
Journal: |
Genomics |
Title: |
Identification and characterization of an inner ear-expressed human melanoma inhibitory activity (MIA)-like gene (MIAL) with a frequent polymorphism that abolishes translation. |
Volume: |
71 |
Issue: |
1 |
Pages: |
40-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stoll R |
Year: |
2008 |
Journal: |
Curr Protein Pept Sci |
Title: |
Extracellular SH3 domain containing proteins--features of a new protein family. |
Volume: |
9 |
Issue: |
3 |
Pages: |
221-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stoll R |
Year: |
2003 |
Journal: |
Protein Sci |
Title: |
Backbone dynamics of the human MIA protein studied by (15)N NMR relaxation: implications for extended interactions of SH3 domains. |
Volume: |
12 |
Issue: |
3 |
Pages: |
510-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bosserhoff AK |
Year: |
2003 |
Journal: |
J Biol Chem |
Title: |
Specific expression and regulation of the new melanoma inhibitory activity-related gene MIA2 in hepatocytes. |
Volume: |
278 |
Issue: |
17 |
Pages: |
15225-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hellerbrand C |
Year: |
2008 |
Journal: |
Gut |
Title: |
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma. |
Volume: |
57 |
Issue: |
2 |
Pages: |
243-51 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hellerbrand C |
Year: |
2005 |
Journal: |
Liver Int |
Title: |
In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers. |
Volume: |
25 |
Issue: |
2 |
Pages: |
357-66 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
MIA2 is expressed specifically in hepatocytes and its expression is controlled by hepatocyte nuclear factor 1 binding sites in the MIA2 promoter [, ]. It inhibits the growth and invasion of hepatocellular carcinomas (HCC) and may act as a tumour suppressor []. A mutation in MIA2 in mice resulted in reduced cholesterol and triglycerides. Since MIA2 localizes to ER exit sites, it may function as an ER-to-Golgi trafficking protein that regulates lipid metabolism []. MIA2 contains an N-terminal SH3-like domain, similar to MIA.MIA (melanoma inhibitory activity) family members include MIA, MIAL, MIA2, and MIA3 (also called TANGO). MIA was found to be strongly expressed and secreted by malignant melanomas. It contains a domain that adopts a Src Homology 3 (SH3) domain-like fold; however, it contains an additional antiparallel beta sheet and two disulfide bonds compared to classical SH3 domains. Unlike classical SH3 domains, MIA does not bind proline-rich ligands [, ]. |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
128
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
128
 |
Fragment?: |
false |
|
•
•
•
•
•
|